- Filed
- May 1, 2025 12:00 AM ET
- Period of report
- —
On SEC.gov
Financials in this filing
| Metric | Period | Value |
|---|---|---|
| Shares Outstanding | Q1 2025 · Apr 28, 2025 | 102.7M sh |
| Long Term Debt | Q1 2025 · Mar 31, 2025 | $92.38M |
| Long Term Debt | Q1 2025 · Dec 31, 2024 | $93.56M |
| Short Term Debt | Q1 2025 · Mar 31, 2025 | $5M |
| Short Term Debt | Q1 2025 · Dec 31, 2024 | $5M |
| Stockholders Equity | Q1 2025 · Mar 31, 2025 | $530.56M |
| Stockholders Equity | Q1 2025 · Dec 31, 2024 | $554.5M |
| Current Liabilities | Q1 2025 · Mar 31, 2025 | $74.67M |
| Current Liabilities | Q1 2025 · Dec 31, 2024 | $79.41M |
| Total Liabilities | Q1 2025 · Mar 31, 2025 | $178.15M |
| Total Liabilities | Q1 2025 · Dec 31, 2024 | $191.93M |
| Current Assets | Q1 2025 · Mar 31, 2025 | $129.44M |
| Current Assets | Q1 2025 · Dec 31, 2024 | $161.51M |
| Total Assets | Q1 2025 · Mar 31, 2025 | $708.72M |
| Total Assets | Q1 2025 · Dec 31, 2024 | $746.42M |
| Cash And Equivalents | Q1 2025 · Dec 31, 2024 | $57.44M |
| Cash And Equivalents | Q1 2025 · Mar 31, 2024 | $65.39M |
| Shares Diluted | Q1 2025 · Mar 31, 2024 | 102.93M sh |
| Stock Repurchased | Q1 2025 · Mar 31, 2024 | $7.74M |
| Capex | Q1 2025 · Mar 31, 2024 | $1.21M |
| Operating Cash Flow | Q1 2025 · Mar 31, 2024 | $14.95M |
| Eps Diluted | Q1 2025 · Mar 31, 2024 | $0.21 |
| Eps Basic | Q1 2025 · Mar 31, 2024 | $0.21 |
| Sga Expense | Q1 2025 · Mar 31, 2024 | $4.06M |
| Net Income | Q1 2025 · Mar 31, 2024 | $21.17M |
| Operating Income | Q1 2025 · Mar 31, 2024 | $16.98M |
| Revenue | Q1 2025 · Mar 31, 2024 | $211.23M |